FDA Inspection 1017172 — Musculoskeletal Transplant Foundation - TSAB
The FDA completed an inspection of Musculoskeletal Transplant Foundation - TSAB on June 16, 2017 in Albany, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 16, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Albany, NY (United States)